Canada Biotechnology & Medical Research

Kane Biotech Inc (KNE)

Track

Kane Biotech Inc. recorded one purchase transaction over the past ninety days, totaling one million CAD. Director Philip Renaud acquired these shares following the most recent earnings report. Despite a twenty-five percent decline in stock value during this period, insider sentiment remains focused on accumulation rather than divestment.
Ticker: KNE Exchange: CVE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Kane Biotech Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.0
Renaud, Philip Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
337.51
Quantity 28,161 +18.6%
Value CA$339,625
2.0
Renaud, Philip Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
456.42
Quantity 35,017 +13.1%
Value CA$2,868,159
2.0
Renaud, Philip Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
343.37
Quantity 6,986 -8.3%
Value CA$4,752,667
1.9
Huizinga, Robert Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.10
Quantity 60,000
Value CA$6,000
2.4
Edwards, Marc Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.10
Quantity 2,000,000 +31.3%
Value CA$200,000
2.0
Renaud, Philip Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.10
Quantity 1,000,000 +6.1%
Value CA$100,000
1.7
Dupuis, Raymond David Eugene Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.10
Quantity 100,000 +10.1%
Value CA$10,000
1.9
Huizinga, Robert Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.13
Quantity 90,000
Value CA$11,250
1.3
Renaud, Richard J. 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
0.10
Quantity 2,500,000 +17.1%
Value CA$250,000
2.4
Edwards, Marc Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.14
Quantity 345,000 +5.9%
Value CA$48,300
2.0
Renaud, Philip Director of Issuer Non-Executive Director
Transaction date
Sale
Price
0.13
Quantity 2,000,000 -10.9%
Value CA$260,000
2.4
Edwards, Marc Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.08
Quantity 125,000 +2.2%
Value CA$10,000
1.3
Renaud, Richard J. 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
0.08
Quantity 3,125,000 +27.2%
Value CA$250,000
1.7
Dupuis, Raymond David Eugene Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.08
Quantity 125,000 +14.5%
Value CA$10,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-28 2026-05-25 B Purchase
2.0
Renaud, Philip

Director of Issuer

Non-Executive Director
28,161 +18.6%
337.51
CA$339,625 		28,161 +18.6% 337.51 CA$339,625
2025-12-18 2025-12-17 B Purchase
2.0
Renaud, Philip

Director of Issuer

Non-Executive Director
35,017 +13.1%
456.42
CA$2,868,159 		35,017 +13.1% 456.42 CA$2,868,159
2025-05-06 2025-05-05 B Purchase
2.0
Renaud, Philip

Director of Issuer

Non-Executive Director
6,986 -8.3%
343.37
CA$4,752,667 		6,986 -8.3% 343.37 CA$4,752,667
2025-01-23 2025-01-17 B Purchase
1.9
Huizinga, Robert

Director of Issuer

Non-Executive Director
60,000
0.10
CA$6,000 		60,000 0.10 CA$6,000
2025-01-23 2025-01-17 B Purchase
2.4
Edwards, Marc

Director of Issuer

Non-Executive Director
2,000,000 +31.3%
0.10
CA$200,000 		2,000,000 +31.3% 0.10 CA$200,000
2025-01-18 2025-01-17 B Purchase
2.0
Renaud, Philip

Director of Issuer

Non-Executive Director
1,000,000 +6.1%
0.10
CA$100,000 		1,000,000 +6.1% 0.10 CA$100,000
2025-01-18 2025-01-17 B Purchase
1.7
Dupuis, Raymond David Eugene

Senior Officer of Issuer

Officer
100,000 +10.1%
0.10
CA$10,000 		100,000 +10.1% 0.10 CA$10,000
2024-09-17 2024-09-13 B Purchase
1.9
Huizinga, Robert

Director of Issuer

Non-Executive Director
90,000
0.13
CA$11,250 		90,000 0.13 CA$11,250
2024-09-12 2024-09-11 B Purchase
1.3
Renaud, Richard J.

10% Security Holder of Issuer

Large shareholder
2,500,000 +17.1%
0.10
CA$250,000 		2,500,000 +17.1% 0.10 CA$250,000
2024-06-25 2024-06-25 B Purchase
2.4
Edwards, Marc

Director of Issuer

Non-Executive Director
345,000 +5.9%
0.14
CA$48,300 		345,000 +5.9% 0.14 CA$48,300
2024-04-22 2024-04-17 S Sale
2.0
Renaud, Philip

Director of Issuer

Non-Executive Director
2,000,000 -10.9%
0.13
CA$260,000 		2,000,000 -10.9% 0.13 CA$260,000
2023-09-19 2023-09-11 B Purchase
2.4
Edwards, Marc

Director of Issuer

Non-Executive Director
125,000 +2.2%
0.08
CA$10,000 		125,000 +2.2% 0.08 CA$10,000
2023-09-18 2023-09-11 B Purchase
1.3
Renaud, Richard J.

10% Security Holder of Issuer

Large shareholder
3,125,000 +27.2%
0.08
CA$250,000 		3,125,000 +27.2% 0.08 CA$250,000
2023-09-13 2023-09-11 B Purchase
1.7
Dupuis, Raymond David Eugene

Senior Officer of Issuer

Officer
125,000 +14.5%
0.08
CA$10,000 		125,000 +14.5% 0.08 CA$10,000
Explore more

More insider trading research around Kane Biotech Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America